<unk>  may cause severe joint pain. The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines like sitagliptin, saxagliptin,<unk> , and alogliptin may cause joint pain that can be severe and disabling. The FDA has added a new Warning and Precaution about this risk to the labels of all medicines in this drug class, called dipeptidyl peptidase-4 (DPP-4) inhibitors. Trajenta's Prescribing Information states the drug is contraindicated for people with bronchial hyperreactivity (for example, asthma).
Linagliptin
Liraglutide
Vildagliptin
Exenatide
Saxagliptin
Sitagliptin
Pioglitazone
Canagliflozin